Snapshot date: 2026-10-18 · Built: 2026-10-19T15:05:26+00:00 · Publication status: PASS

COMPANY RESEARCH

Bayer Aktiengesellschaft

BAYN.DE · Germany · Healthcare · Drug Manufacturers—General

INSIDER SIGNAL

Insider activity score：62.2 / 100

1 insiders · 1 purchase events · €3.08m net purchases

Europe #240 · Germany #26

WHY THIS SIGNAL?

Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+21.0 / 35

How many distinct insiders bought in the cluster

Purchase size+24.2 / 25

Purchase value relative to company size and liquidity

Role+13.0 / 20

The seniority and relevance of participating insiders

Recency+0.0 / 10

How recently the purchases occurred

Conviction+10.0 / 10

How clearly buying stands out from other activity

What is holding the score back?

⚠ Buyer breadth is moderate · fewer than 4 distinct filers
⚠ Insider role contributes less on the current role scale
⚠ Purchase activity is becoming less recent

The role contribution uses the inverted role input of the current European model.

BUYING PROFILE

1 events · 1 insiders · 180d

Cluster 0%Repeat 0%Independent 100%Large 0%

Percentages are mutually exclusive and sum to 100%.

Buying concentration

100%

Largest buyer：Jeffrey and Laura Ubben 2000 Trust · 1.14m EUR
Gross qualified purchase transaction-line value：1.14m EUR

The headline € total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.

This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.

Key purchase quotes (filing currency)

Filer	Price per unit	Trade date
Jeffrey and Laura Ubben 2000 Trust	45.88–48.41 EUR	Jun 30, 2026

Model details

Cluster breakdown (does not change the score)

15-day buyer breadth (count): 1 distinct reported filers
Peak time window: 2026-06-30 to 2026-06-30
Current breadth input: 0.600 (capped at 4+ buyers)
Buyer independence: Not yet measured; related-party fields are not cross-market comparable

What the filings show

🟢 Recent eligible purchase
Jeffrey and Laura Ubben 2000 Trust · 1.14m EUR · Price 45.88–48.41 EUR · Jun 30, 2026

Insider vs stock price

1 purchase day(s), 125 purchase line(s) in the 180-day window.

Daily close (EUR)Day with an insider purchase

Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.

If you had followed the purchase

Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.

Amount put in (EUR)

Made public	Insiders	In this stock, now	In the median peer stock, now	Difference
2026-07-01	1	899 −10.1%	955 −4.5%	−56 −5.6 pts

0 of 1 disclosure day(s) ended ahead of the median peer stock.

Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (88 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.

Insider timeline

One insider bought, once (30 Jun). The share closed at 48.41 that day and at 44.05 most recently (−9.0%).

Tap an item for what it means.

●A purchase: the bigger the dot, the more was bought

Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.

Blue line: this share's price, +10.2% over these six months

The closing price of each day, from 39.97 on 2026-04-21 to 44.05 on 2026-10-07. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.

Dashed line: the typical stock on the same exchange, −5.7%

Taken from the 88 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share +10.2%, the typical one −5.7%, 15.9 points ahead. It is not an index and not a comparison within one industry.

▂Grey bars: companies across Europe disclosing purchases each week

A taller bar is a week in which more companies disclosed insider purchases.

This company: insiders buying per month, last 12 months

Nov

Dec

Jan

Feb

Mar

Apr

May

1Jun

Jul

Aug

Sep

Oct

Darker bars are inside the 180-day window above.

Who traded

Insider	Role	Purchases	Sales	Bought	First purchase	Share price since	Earlier purchases
Jeffrey and Laura Ubben 2000 Trust	Role not classified	1	—	1.1M EUR	2026-06-30	−9.0%	fewer than 5 completed

Why this score? · Model details

Priority = 100 × Σ(fixed weight × 0–1 rule-based input)

Factor	Weight	This company input	Point contribution
15-day buyer breadth (count)	35%	0.600	21.0
Qualified-buy size	25%	0.969	24.2
Role informativeness (inverted)	20%	0.350	7.0
Recency	10%	0.001	0.0
Buy/sell conviction	10%	1.000	10.0

This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.

BULL VS BEAR

Two readings of this buying

The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.

Since 2026-10-13, neither column has changed. All bull and bear lists, and what followed each line in the past →

Where the evidence comes from

The purchases themselves carry no bull line, and company results argue against (loss-making). No data is held for: company actions.

The insider purchases themselvesBearvalue concentrated in one buyer, small purchases, latest purchase is old2 checked, under the threshold · 3 missing
Share price and trading2 checked, under the threshold
Short sellers1 checked, under the threshold
Company resultsBearloss-making1 missing
Company actions1 missing

Bull case · the buying is informative

Nothing held here goes beyond the fact that an insider bought.

Bear case · discount it

Jeffrey and Laura Ubben 2000 Trust accounts for 100% of the value bought. The other 2 buyers add names more than money.Record: after 3,396 earlier disclosures like this, the median 60-session excess return was −3.4%, within 1 percentage point of all comparable disclosures (−3.5%).
Net purchases of €3.1M are <0.01% of the company's market value (€49.9bn): a visible sum, a small one against the business.
The latest purchase was 109 days ago (2026-06-30). A reporting period has passed since, so what the buyers knew then may already be public.
Company resultsThe company is loss-making on the latest captured figures: profit margin −3.8%, return on equity −5.7%.

Evidence still missing

No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
Only one reading of profitability is held (profit margin −3.8%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
The next scheduled results are on 2026-11-03. They are the first hard test of either reading.
European notifications have no field saying whether a purchase was pre-arranged; there is no counterpart to the US 10b5-1 box. None of the 125 purchase lines mentions a plan, but a bare “Kauf” does not rule one out.
The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.

Checked and under the threshold: 5

BullAt most 1 insider bought within any 15 days. Counted for the bull side from 3.
BearNo insider sale is recorded in the same 180 days.
BearThe share price changed +9.8% over six months (three months −13%, one month −11%) and stands 18% below its 52-week high. Counted for the bear side from a fall of 20%.
BearOver three months the share price changed −13% and the median of 271 Healthcare companies changed −6.3%: behind by 7 points. Counted for the bear side from 20 points behind.
BearPublished net short positions total 0.50% of the share capital across 1 named holder. Counted for the bear side from 2%.

Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.

Signal history

62.2 / 100

Latest recorded score

→ +0.0 ptssince the first recorded snapshot on 2026-09-24; 24 calendar days observed

Recorded snapshots: 20
First snapshot: 2026-09-24

There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.

Why did it change?

Less than 30 days of comparable history is available, so factor movement is not yet decomposed.

Signal score history

Fixed 0–100 scale; dates are spaced by calendar time.

Recent recorded points

Sep 24, 202662.2
Oct 1, 202662.2
Oct 6, 202662.2
Oct 12, 202662.2
Oct 18, 202662.2

View all recorded scores

Snapshot date	Signal score
2026-09-24	62.2
2026-09-25	62.2
2026-09-28	62.2
2026-09-29	62.2
2026-09-30	62.2
2026-10-01	62.2
2026-10-02	62.2
2026-10-03	62.2
2026-10-04	62.2
2026-10-05	62.2
2026-10-06	62.2
2026-10-07	62.2
2026-10-08	62.2
2026-10-09	62.2
2026-10-12	62.2
2026-10-13	62.2
2026-10-14	62.2
2026-10-15	62.2
2026-10-16	62.2
2026-10-18	62.2

Sector context

Healthcare

Buying breadth: 6.1% (48 / 792 issuers)
Sector rank: #11 / 12
7D breadth change: -0.4 pp · vs 2026-10-12 (6d)
30D breadth change: History building

This is sector-level research context. It does not affect the Insider Signal or ranking.

View Europe sector research →

Insider profile outcomes

Historical performance following insider filings. The company role is translated below each name while preserving the original title.

Excess return = stock return − DAX return over the same period.
Hit rate = completed events with positive excess return ÷ total completed events.
Price coverage = valid point-in-time prices ÷ events mature enough for that period.
Returns start on the first shared trading session on or after publication.
Small-sample rule: n<5 is shown for transparency and is not scored.

Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.

Dr. Judith HartmannManagement Board Member (Vorstand)1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	100.0% (1/1)	+3.6%	+3.6%	+3.6%
20D	1Small sample	100.0% (1/1)	100.0% (1/1)	+37.4%	+37.4%	+37.4%
60D	1Small sample	100.0% (1/1)	100.0% (1/1)	+32.2%	+32.2%	+32.2%
120D	0No data	Awaiting maturity	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ €100k

1/1

Cluster buying · 15D

1/1

Buying the dip · ≥20% below prior 52W high

1/1

Routine / opportunistic

Not classifiable

Jeffrey and Laura Ubben 2000 TrustIn enger Beziehung1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	0.0% (0/1)	-3.2%	-3.2%	-3.2%
20D	1Small sample	100.0% (1/1)	0.0% (0/1)	-9.3%	-9.3%	-9.3%
60D	1Small sample	100.0% (1/1)	0.0% (0/1)	-6.2%	-6.2%	-6.2%
120D	0No data	Awaiting maturity	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ €100k

1/1

Cluster buying · 15D

0/1

Buying the dip · ≥20% below prior 52W high

0/1

Routine / opportunistic

Not classifiable

SF Investment One Pte Ltd.In enger Beziehung1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	100.0% (1/1)	+3.6%	+3.6%	+3.6%
20D	1Small sample	100.0% (1/1)	100.0% (1/1)	+47.5%	+47.5%	+47.5%
60D	1Small sample	100.0% (1/1)	100.0% (1/1)	+30.6%	+30.6%	+30.6%
120D	0No data	Awaiting maturity	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ €100k

1/1

Cluster buying · 15D

0/1

Buying the dip · ≥20% below prior 52W high

1/1

Routine / opportunistic

Not classifiable

Market context

PRICE PERFORMANCE

-10.8%

-13.1%

+9.8%

12M

+58.6%

VOLATILITY & LIQUIDITY

Volatility: 41.9%
Beta: 0.83
Avg daily volume: €61.5M

VALUATION

Market cap: €49.9B
P/E: —

FUNDAMENTALS

Profit margin: -3.8%
ROE: -5.7%
Industry: Drug Manufacturers - General

Prices to 07 Oct 2026: price cache (Eulerpool). From OpenBB/yfinance, captured 28 Sep 2026: Market cap, Profit margin, ROE, Beta, Industry. It does not affect the insider score or rank.

Disclosed net short positions

Disclosed total: 0.50%
Named holders: 1
Latest position date: 21 Sep 2026

Holder	Net short, % of issued share capital	Position date
AQR Capital Management, LLC	0.50%	21 Sep 2026

Only positions of 0.5% or more are published, so the total is a lower bound, not total short interest. A row with an old position date may be a disclosure that was never withdrawn. Source: Bundesanzeiger · read 18 Oct 2026

Aggregate net short: 1.40%
Latest position date: 14 Oct 2026

The FCA publishes one aggregate figure per issuer, the sum of all positions notified to it, and does not name the holders. Source: FCA · read 18 Oct 2026

Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.

Insiders' buying price vs the latest close

The latest close in the price history is more than a week old.

Buying size vs market trading

Market history is too old for this snapshot; ratios are withheld.

Market-data coverage: 255 verified sessions · Latest session: 2026-10-07 · Ratio status: Unavailable

Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.

Latest news

No news has been captured for this company.

Regulatory filings

Pressetext announcement · published 2026-07-01 · trade date 2026-06-30

Filing evidence

These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.

Excluded transactions & classification

1 qualifying purchase disclosure(s) · 125 transaction line(s)

Jun 30, 2026Kauf

Jeffrey and Laura Ubben 2000 Trust · In enger Beziehung

Aktie · 13 shares × 46.63378 EUR · 606.23914 EUR

Open filing

Jun 30, 2026Kauf

Jeffrey and Laura Ubben 2000 Trust · In enger Beziehung

Aktie · 78 shares × 46.67459 EUR · 3640.61802 EUR

Open filing

Jun 30, 2026Kauf

Jeffrey and Laura Ubben 2000 Trust · In enger Beziehung

Aktie · 178 shares × 45.9 EUR · 8170.2 EUR

Open filing

Unfold all 97 remaining filing row(s)

Transaction date	Published	Filer	Role	Transaction	Instrument	Price (local currency)	Quote currency	Volume	Reported value (local currency)	Source
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	45.94 EUR	EUR	167	7671.98 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.14 EUR	EUR	180	8305.2 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.14 EUR	EUR	220	10150.8 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	45.88 EUR	EUR	338	15507.44 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	45.88 EUR	EUR	72	3303.36 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.16 EUR	EUR	218	10062.88 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.16 EUR	EUR	144	6647.04 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.31743 EUR	EUR	20	926.3486 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.43449 EUR	EUR	45	2089.55205 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.44315 EUR	EUR	58	2693.7027 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.43933 EUR	EUR	19	882.34727 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.7553 EUR	EUR	66	3085.8498 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.63358 EUR	EUR	37	1725.44246 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.64252 EUR	EUR	73	3404.90396 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.6332 EUR	EUR	73	3404.2236 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.70901 EUR	EUR	67	3129.50367 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.80022 EUR	EUR	74	3463.21628 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.77906 EUR	EUR	85	3976.2201 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.85 EUR	EUR	144	6890.4 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.85 EUR	EUR	144	6890.4 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.85 EUR	EUR	104	4976.4 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.805 EUR	EUR	540	25814.7 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.56239 EUR	EUR	111	5279.42529 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.51 EUR	EUR	1077	51168.27 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.25 EUR	EUR	319	15072.75 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.9206 EUR	EUR	27	1266.8562 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.51 EUR	EUR	279	12976.29 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.66358 EUR	EUR	86	4013.06788 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.7051 EUR	EUR	76	3549.5876 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.66 EUR	EUR	604	28182.64 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	46.66 EUR	EUR	4	186.64 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.00738 EUR	EUR	9	423.06642 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.04894 EUR	EUR	28	1317.37032 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.05817 EUR	EUR	9	423.52353 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.06388 EUR	EUR	44	2070.81072 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.08554 EUR	EUR	50	2354.277 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.11581 EUR	EUR	13	612.50553 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.20147 EUR	EUR	30	1416.0441 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.21883 EUR	EUR	65	3069.22395 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.22007 EUR	EUR	15	708.30105 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.14048 EUR	EUR	72	3394.11456 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.12119 EUR	EUR	44	2073.33236 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.00639 EUR	EUR	51	2397.32589 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.00717 EUR	EUR	22	1034.15774 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.03 EUR	EUR	452	21257.56 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.05265 EUR	EUR	26	1223.3689 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.09337 EUR	EUR	28	1318.61436 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.09436 EUR	EUR	32	1507.01952 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.06169 EUR	EUR	37	1741.28253 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.1263 EUR	EUR	35	1649.4205 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.12153 EUR	EUR	34	1602.13202 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.14375 EUR	EUR	36	1697.175 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.12754 EUR	EUR	39	1837.97406 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.09796 EUR	EUR	36	1695.52656 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.77 EUR	EUR	754	36018.58 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.77 EUR	EUR	112	5350.24 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.1015 EUR	EUR	46	2166.669 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.12573 EUR	EUR	35	1649.40055 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.13298 EUR	EUR	46	2168.11708 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.18016 EUR	EUR	35	1651.3056 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.18016 EUR	EUR	48	2264.64768 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.22 EUR	EUR	34	1605.48 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.25731 EUR	EUR	29	1370.46199 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.25731 EUR	EUR	18	850.63158 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.31557 EUR	EUR	35	1656.04495 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.31534 EUR	EUR	16	757.04544 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.24783 EUR	EUR	36	1700.92188 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.25043 EUR	EUR	26	1228.51118 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.26253 EUR	EUR	35	1654.18855 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.42199 EUR	EUR	23	1090.70577 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.73 EUR	EUR	277	13221.21 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.72173 EUR	EUR	11	524.93903 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.455 EUR	EUR	258	12243.39 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.80929 EUR	EUR	93	4446.26397 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.78091 EUR	EUR	18	860.05638 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.395 EUR	EUR	323	15308.585 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.53582 EUR	EUR	26	1235.93132 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.12 EUR	EUR	174	8372.88 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.12 EUR	EUR	36	1732.32 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.12 EUR	EUR	180	8661.6 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.07 EUR	EUR	326	15670.82 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.02 EUR	EUR	241	11572.82 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.39544 EUR	EUR	35	1658.8404 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.4129 EUR	EUR	25	1185.3225 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.43914 EUR	EUR	14	664.14796 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.4442 EUR	EUR	35	1660.547 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.51761 EUR	EUR	30	1425.5283 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.52707 EUR	EUR	47	2233.77229 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.53105 EUR	EUR	35	1663.58675 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.58497 EUR	EUR	36	1713.05892 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.74415 EUR	EUR	58	2769.1607 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.84342 EUR	EUR	118	5645.52356 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.03583 EUR	EUR	19	912.68077 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.09 EUR	EUR	95	4568.55 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	48.03 EUR	EUR	108	5187.24 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.53323 EUR	EUR	35	1663.66305 EUR	Open filing
2026-06-30	2026-07-01	Jeffrey and Laura Ubben 2000 Trust	In enger Beziehung	Kauf	Aktie	47.51961 EUR	EUR	49	2328.46089 EUR	Open filing

Showing 100 of 125 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.

Other disclosed transactions · excluded from score

The underlying filing feed is unavailable in this snapshot; this is not a claim that no filings exist.

Snapshot & identity

Snapshot date: 2026-10-18
Ticker: BAYN.DE
ISIN: DE000BAY0017
Sector: Healthcare
Industry: Drug Manufacturers—General

Company logos by Parqet

Bayer Aktiengesellschaft

WHY THIS SIGNAL?

Score anatomy

What is holding the score back?

BUYING PROFILE

Buying concentration

Key purchase quotes (filing currency)

Cluster breakdown (does not change the score)

What the filings show

Insider vs stock price

If you had followed the purchase

Insider timeline

This company: insiders buying per month, last 12 months

Who traded

Two readings of this buying

Where the evidence comes from

Bull case · the buying is informative

Bear case · discount it

Evidence still missing

Signal score history

Recent recorded points

Sector context

Insider profile outcomes

Market context

PRICE PERFORMANCE

VOLATILITY & LIQUIDITY

VALUATION

FUNDAMENTALS

Disclosed net short positions

Insiders' buying price vs the latest close

Buying size vs market trading

Latest news

Regulatory filings

Filing evidence

Other disclosed transactions · excluded from score

Snapshot & identity

Share this page